Does GLYCOPYRRONIUM\INDACATEROL Cause Mobility decreased? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with GLYCOPYRRONIUM\INDACATEROL. This represents 0.6% of all adverse event reports for GLYCOPYRRONIUM\INDACATEROL.
12
Reports of Mobility decreased with GLYCOPYRRONIUM\INDACATEROL
0.6%
of all GLYCOPYRRONIUM\INDACATEROL reports
1
Deaths
4
Hospitalizations
How Dangerous Is Mobility decreased From GLYCOPYRRONIUM\INDACATEROL?
Of the 12 reports, 1 (8.3%) resulted in death, 4 (33.3%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLYCOPYRRONIUM\INDACATEROL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does GLYCOPYRRONIUM\INDACATEROL Cause?
Dyspnoea (400)
Chronic obstructive pulmonary disease (291)
Cough (232)
Pneumonia (205)
Wheezing (203)
Lung neoplasm malignant (138)
Oedema peripheral (130)
Death (126)
Malaise (119)
Gastrooesophageal reflux disease (114)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GLYCOPYRRONIUM\INDACATEROL Alternatives Have Lower Mobility decreased Risk?
GLYCOPYRRONIUM\INDACATEROL vs GOLD
GLYCOPYRRONIUM\INDACATEROL vs GOLD THIOMALATE
GLYCOPYRRONIUM\INDACATEROL vs GOLIMUMAB
GLYCOPYRRONIUM\INDACATEROL vs GOLODIRSEN
GLYCOPYRRONIUM\INDACATEROL vs GONADORELIN